SARS-CoV-2 Circulation in the School Setting: A Systematic Review and Meta-Analysis.
SARS-CoV-2
contract tracing
infections
meta-analysis
schools
screening
students
susceptibility
teachers
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
28 04 2022
28 04 2022
Historique:
received:
13
03
2022
revised:
20
04
2022
accepted:
26
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
18
5
2022
Statut:
epublish
Résumé
The contribution of children to viral spread in schools is still debated. We conducted a systematic review and meta-analysis of studies to investigate SARS-CoV-2 transmission in the school setting. Literature searches on 15 May 2021 yielded a total of 1088 publications, including screening, contact tracing, and seroprevalence studies. MOOSE guidelines were followed, and data were analyzed using random-effects models. From screening studies involving more than 120,000 subjects, we estimated 0.31% (95% confidence interval (CI) 0.05-0.81) SARS-CoV-2 point prevalence in schools. Contact tracing studies, involving a total of 112,622 contacts of children and adults, showed that onward viral transmission was limited (2.54%, 95% CI 0.76-5.31). Young index cases were found to be 74% significantly less likely than adults to favor viral spread (odds ratio (OR) 0.26, 95% CI 0.11-0.63) and less susceptible to infection (OR 0.60; 95% CI 0.25-1.47). Lastly, from seroprevalence studies, with a total of 17,879 subjects involved, we estimated that children were 43% significantly less likely than adults to test positive for antibodies (OR 0.57, 95% CI 0.49-0.68). These findings may not applied to the Omicron phase, we further planned a randomized controlled trial to verify these results.
Identifiants
pubmed: 35564779
pii: ijerph19095384
doi: 10.3390/ijerph19095384
pmc: PMC9099553
pii:
doi:
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Pediatr Allergy Immunol. 2021 May;32(4):762-770
pubmed: 33512035
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):449-455
pubmed: 33764961
Lancet Child Adolesc Health. 2021 Apr;5(4):256-264
pubmed: 33571450
Euro Surveill. 2020 Sep;25(36):
pubmed: 32914746
Lancet Infect Dis. 2022 Jul;22(7):977-989
pubmed: 35378075
MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):377-381
pubmed: 33735161
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):437-441
pubmed: 33764962
Pediatr Res. 2021 Nov;90(5):1073-1080
pubmed: 34304252
J Med Virol. 2021 Mar;93(3):1828-1831
pubmed: 33230857
J Sch Health. 2021 May;91(5):347-355
pubmed: 33768529
BMC Infect Dis. 2021 May 4;21(1):417
pubmed: 33947340
JAMA Pediatr. 2021 Jun 1;175(6):586-593
pubmed: 33480966
Clin Infect Dis. 2022 Jan 7;74(1):66-73
pubmed: 33709138
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Nat Med. 2021 Dec;27(12):2111-2119
pubmed: 34707318
Lancet. 2021 Oct 2;398(10307):1217-1229
pubmed: 34534517
Cell Rep Med. 2021 Nov 16;2(11):100452
pubmed: 34723225
J Infect. 2021 Jul;83(1):e8-e10
pubmed: 34023366
Lancet Reg Health West Pac. 2022 Feb;19:100369
pubmed: 35098182
Ital J Pediatr. 2021 Feb 2;47(1):23
pubmed: 33531046
Stat Med. 2001 Feb 28;20(4):641-54
pubmed: 11223905
Clin Infect Dis. 2021 Jul 15;73(2):e458-e465
pubmed: 32649743
J Glob Health. 2020 Dec;10(2):021104
pubmed: 33437465
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Nat Commun. 2022 Jan 27;13(1):554
pubmed: 35087051
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33574041
JAMA Netw Open. 2021 Sep 1;4(9):e2126447
pubmed: 34550382
Euro Surveill. 2020 May;25(21):
pubmed: 32489179
Int J Environ Res Public Health. 2021 Mar 08;18(5):
pubmed: 33800392
BMJ Paediatr Open. 2021 Mar 24;5(1):e001036
pubmed: 34192197
J Glob Health. 2020 Dec;10(2):021101
pubmed: 33312511
Clin Microbiol Infect. 2021 Mar;27(3):474.e1-474.e3
pubmed: 33309698
Stat Med. 2002 Jun 15;21(11):1559-73
pubmed: 12111920
BMJ. 2021 Mar 17;372:n616
pubmed: 33731327
Sci Rep. 2021 Nov 17;11(1):22373
pubmed: 34789783
CMAJ Open. 2021 Aug 24;9(3):E810-E817
pubmed: 34429325
Int J Infect Dis. 2021 Feb;103:246-256
pubmed: 33227520
Nat Commun. 2021 Feb 16;12(1):1073
pubmed: 33594076
Lancet Child Adolesc Health. 2020 Jun;4(6):421
pubmed: 32302537
MMWR Morb Mortal Wkly Rep. 2021 May 28;70(21):779-784
pubmed: 34043610
J Korean Med Sci. 2020 Nov 30;35(46):e414
pubmed: 33258334
PLoS One. 2021 Sep 2;16(9):e0257046
pubmed: 34473776
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
Diagnostics (Basel). 2021 Sep 29;11(10):
pubmed: 34679495
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413743
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):
pubmed: 33827987
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):442-448
pubmed: 33764967
Euro Surveill. 2020 Jul;25(29):
pubmed: 32720636
J Public Health (Oxf). 2022 Mar 7;44(1):e26-e35
pubmed: 34179987
Lancet Reg Health Eur. 2021 Jun;5:100092
pubmed: 34104904
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
JAMA. 2021 Apr 20;325(15):1561-1562
pubmed: 33605978
Clin Infect Dis. 2022 Jan 29;74(2):319-326
pubmed: 33864375
Nat Med. 2021 Dec;27(12):2078-2079
pubmed: 34824459
Lancet Infect Dis. 2021 Feb;21(2):193-202
pubmed: 33729915
BMJ Open. 2021 Jun 10;11(6):e049876
pubmed: 34112645
Euro Surveill. 2020 Dec;25(49):
pubmed: 33303065
Euro Surveill. 2021 Apr;26(15):
pubmed: 33860747
Clin Infect Dis. 2021 Nov 16;73(10):1871-1878
pubmed: 33704422
Front Psychol. 2021 Sep 16;12:746289
pubmed: 34603162
Front Pediatr. 2021 Mar 16;9:645577
pubmed: 33796490
Clin Infect Dis. 2020 Jul 28;71(15):825-832
pubmed: 32277759
Epidemiol Rev. 1987;9:1-30
pubmed: 3678409